12:00 AM
Nov 19, 2012
 |  BC Week In Review  |  Company News  |  Deals

biOasis, AstraZeneca deal

biOasis partnered with AstraZeneca's MedImmune LLC biologics unit to evaluate biOasis' Transcend technology in transporting to the...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >